Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 1471 AL 1485

Effects of light therapy on sleep and anxiety in Parkinson's disease: A pilot trial

Shen Y, Li HX, Dai J, Zhou QJ, Tao MX, Xie WY, Lou H, Liu JY, Gao F, Hu H, Mao CJ, Wang F, Liu CF.

J Affect Disord. 2026 Nov 1;412:122121. doi: 10.1016/j.jad.2026.122121. Epub 2026 Jun 9.

Impaired glymphatic clearance as a mechanistic link between brain aging and neurodegenerative disease pathogenesis

Khan A, Alzahrani AR, Rehman ZU, Singla N, Shakeel F, Ali YH, Saeed IK, Imran M.

Ageing Res Rev. 2026 Aug;120:103202. doi: 10.1016/j.arr.2026.103202. Epub 2026 Jun 8.

Role of 5α-reductase inhibitors in Parkinson's disease: Gambling or not?

Hussein NR, Al-Kuraishy HM, Fahad EH, Sulaiman GM, Mohammed HA, Al-Gareeb AI, Albuhadily AK.

J Steroid Biochem Mol Biol. 2026 Oct;263:107056. doi: 10.1016/j.jsbmb.2026.107056. Epub 2026 Jun 8.

Wearable technologies in neurorehabilitation and cardiac rehabilitation: A narrative review

Micali G, Corallo F, Cappadona I, Giambò FM, Duca A, D'Aleo P, Anselmo A, Bramanti A, Garofano M, Bramanti P, Pagano M.

J Bodyw Mov Ther. 2026 Jul;47:80-89. doi: 10.1016/j.jbmt.2026.03.023. Epub 2026 Mar 20.

Time vortex: the circadian-dopaminergic dialogue in Parkinson's disease

Zhou M, Xu Y, Liu Y, Wang J, Hou K, An Z, Wei J.

NPJ Parkinsons Dis. 2026 Jun 9. doi: 10.1038/s41531-026-01429-1. Online ahead of print.

Salivary protein macromolecules as diagnostic and therapeutic biomarkers linking oral health and neurodegenerative diseases-emerging mechanisms and future perspectives

Dhingra P, Kumar A, Raj PM, Patel P, Sahu KK, Das Kurmi B.

Inflammopharmacology. 2026 Jul;34(7):4311-4326. doi: 10.1007/s10787-026-02220-7. Epub 2026 Jun 9.

Cross-Cultural Adaptation and Psychometric Evaluation of the Turkish Version of the Exercise-Specific Parkinson's Disease Questionnaire

Yalçın M, Kahraman T, Dönmez Çolakoğlu B, Genç A.

Brain Behav. 2026 Jun;16(6):e71447. doi: 10.1002/brb3.71447.

Harnessing the Ocean's Power: Fucoidan as a Novel Neuroregenerative Agent

Wu Q, Hui X, Cui A, Meng X.

Drug Dev Res. 2026 Jun;87(4):e70331. doi: 10.1002/ddr.70331.

Gastroparesis in Parkinson's disease: Diagnostic and clinical implications for optimizing pharmacological treatment

Damiens Q, Mille V, Faure J, Toussirot E, Valnet-Rabier MB, Béreau M.

J Parkinsons Dis. 2026 Aug;16(5):842-863. doi: 10.1177/1877718X261432743. Epub 2026 Jun 10.

CRISPR-Based Gene Therapy for Brain Disease

Khajouei F, Ghaemi A, Abnous K, Taghdisi SM, Ramezani M, Alibolandi M.

Mol Neurobiol. 2026 Jun 10;63(1):686. doi: 10.1007/s12035-026-05966-x.

Unravelıng non-canonıcal Wnt sıgnalıng ın neural development and dısorders: a revıew of Wnt/PCP and Wnt/ca(²⁺) pathways

Palabiyik AA, Palabiyik E.

Mol Biol Rep. 2026 Jun 10;53(1):929. doi: 10.1007/s11033-026-12120-2.

Validating automated speech timing methods in clinical and healthy speakers across sentence, paragraph, and monologue tasks

Arzbecker LJ, Tjaden K.

J Acoust Soc Am. 2026 Jun 1;159(6):5238-5257. doi: 10.1121/10.0044119.

Global prevalence and disability burden of brain disorders: Impact of neurological, mental, and substance use disorders

Salehinejad MA, Fathi Jouzdani A, Bandeira ID, Bender S, Bikson M, Castelo-Branco M, Cohen Kadosh R, Costanzo F, Croarkin PE, Desarkar P, Dyke K, Eickhoff S, Fitzgerald PB, Hartwigsen G, Koenig J, Martino D, Menghini D, Mirfazeli FS, Moliadze V, Nitsche MA, Oberman LM, Siniatchkin M, Vaziri Z, Vicario CM, Vöckel J, Wischnewski M, Wolters CH, Zangen A, Zaehle T, Zomorrodi R, Brunoni AR.

Neurosci Biobehav Rev. 2026 Sep;188:106808. doi: 10.1016/j.neubiorev.2026.106808. Epub 2026 Jun 10.

Dual-target gene therapy in Parkinson's disease: a multicenter phase 1 trial

Niu M, Guo J, Yang Y, Xu Q, Cheng C, Li H, Luo N, Zhou H, Zhang P, Li Y, Wang N, Wang C, Li D, Lin Z, Huang P, Yang Z, Yang Z, Song Y, Zheng J, Jiang W, Du Z, Qi Y, Peng H, Tan Y, Hu X, Xiao X, Shen L, Lin J, Liu J.

Nat Med. 2026 Jul;32(7):2602-2609. doi: 10.1038/s41591-026-04436-0. Epub 2026 Jun 10.

What can we learn from eye movements in movement disorders and Parkinson's disease?

Ravat P, Ghasia FF, Shaikh AG.

Curr Opin Neurol. 2026 Aug 1;39(4):415-422. doi: 10.1097/WCO.0000000000001501. Epub 2026 Jun 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias